1999
DOI: 10.1016/s0898-6568(99)00056-x
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacological and Functional Characterization of Bradykinin Receptors in Rat Cultured Vascular Smooth Muscle Cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
25
0

Year Published

2002
2002
2016
2016

Publication Types

Select...
9

Relationship

3
6

Authors

Journals

citations
Cited by 22 publications
(27 citation statements)
references
References 34 publications
2
25
0
Order By: Relevance
“…The bradykinin-induced response was inhibited by nifedipine and verapamil (30). In the present study, the release of ATP evoked by the peptide was attenuated by nifedipine and verapamil, voltagegated Ca…”
Section: +supporting
confidence: 58%
See 1 more Smart Citation
“…The bradykinin-induced response was inhibited by nifedipine and verapamil (30). In the present study, the release of ATP evoked by the peptide was attenuated by nifedipine and verapamil, voltagegated Ca…”
Section: +supporting
confidence: 58%
“…Then the cells were kept for 25 min in the solution (37°C) with and without test antagonists. After the cells had been exposed to the agonist, the dish medium was replaced with 1% PCA solution (pH 1.11) or the cell lysis buffer containing 1% Triton-X at each time point (10,20,30, and 60 s). The experiment with the PCA solution was undertaken as follows.…”
Section: Cytosolic Accumulation Of Atpmentioning
confidence: 99%
“…VSMCs were stimulated with bradykinin (10 Ϫ6 mol/l), acutely (10 -30 min) or chronically (1-24 h). In some experiments, cells were preexposed for 30 min to Hoe-140 [bradykinin-2 (B 2) receptor antagonist; 10 Ϫ5 mol/l], chelerythrine (PKC inhibitor; 10 Ϫ5 mol/l), U-73122 (PLC inhibitor; 10 Ϫ5 mol/l) or 2-aminoethoxydiphenyl borate (2-APB; TRPM7 inhibitor; 10 Ϫ5 mol/l, 2 h pretreatment) (18,50,52).…”
Section: Methodsmentioning
confidence: 99%
“…Activation of both receptors promotes intracellular calcium mobilization by inositol 1,4,5-triphosphate, production by phospholipase C-beta activity, and evoke release of nitric oxide and prostaglandins (Marceau and Regoli, 2004;Thornton et al, 2010). Both receptor subtypes are expressed by many cell types, including neurons (Couture et al, 2001), glial cells (Gimpl et al, 1992;Stephens et al, 1993;Noda et al, 2003), endothelial cells (Miyamoto et al, 1999) and vascular smooth muscle cells (Yang et al, 1999). In the human brain, components of KKS were found specifically in the thalamus, hypothalamus, cerebral cortex and spinal cord (Raidoo and Bhoola, 1997).…”
Section: The Kallikrein-kinin Systemmentioning
confidence: 99%